FIBRILIN vial 3 ml

Organization name

LABORATORIOS FARMACÉUTICOS ROVI, S.A.

SRN

ES-MF-000014579

Manufacturer status

Active

1 warning recorded — scroll inside the panel to see all entries.

• CW010

  FIBRILIN está contraindicado en pacientes con hipersensibilidad a las heparinas o a cualquiera de los excipientes presentes en la formulación. Aun considerando la mínima concentración de heparina, no suficiente para presentar actividad sistémica, se considera fundamental el criterio médico en el uso de este producto en los casos de: - Amenaza de aborto. - Aneurisma cerebral o disecante de aorta, excepto en asociación con la cirugía correctiva. - Hemorragia cerebrovascular confirmada o sospechada. - Hemorragia activa incontrolable. - Hipertensión grave no controlada. - Trombocitopenia grave inducida por heparina en los últimos meses.

Primary placement in Spain; available across 2 countries total.

Trade name

not provided

UDI-DI code

08436583241240

Basic UDI-DI

843658324FIBRILIN7Q

Reference / catalog number

FIBRILIN vial 3 ml

Issuing entity

GS1

Risk category

Class III

Applicable legislation

MDR [Regulation (EU) 2017/745 on medical devices]

Status

On the market

Quantity

1

Additional product description

—

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification

European Medical Device Nomenclature — the EU product classification assigned to this device.

• V9099VARIOUS DEVICES NOT INCLUDED IN OTHER CLASSES - OTHER

Certificate health across this manufacturer's portfolio.